Payer Perspectives on Genomic Testing in the United States: A systematic literature review

J Wiedower, HS Smith, CL Farrell, V Parker, L Rebek… - Genetics in …, 2024 - Elsevier
Purpose Healthcare stakeholders' perspectives on the value of genomic testing vary widely
and directly impact the access and practice of genomic medicine. A review of United States …

Potential corporate uses of polygenic indexes: Starting a conversation about the associated ethics and policy issues

MN Meyer, NW Papageorge, E Parens… - The American Journal of …, 2024 - cell.com
Some commercial firms currently sell polygenic indexes (PGIs) to individual consumers,
despite their relatively low predictive power. It might be tempting to assume that because the …

Still using genetic data? A comparative review of Canadian life insurance application forms before and after the GNDA

A Fernando, E Kondrup, K Cheung, D Uberoi, Y Joly - FACETS, 2024 - facetsjournal.com
Genetic testing's increased availability has raised concerns about “genetic
discrimination”(GD), where individuals may face unfair treatment, particularly when …

Genetic testing and insurance implications: Surveying the US general population about discrimination concerns and knowledge of the Genetic Information …

AER Prince, WR Uhlmann, SM Suter… - … and insurance review, 2021 - Wiley Online Library
Globally, due to public concerns of genetic discrimination, some countries and insurance
industries have adopted policies restricting insurer use of genetic information, such as the …

“Uninsurable because of a genetic test”: a qualitative study of consumer views about the use of genetic test results in Australian life insurance

C Muller, L Gallacher, L Keogh… - European Journal of …, 2024 - nature.com
Genetic testing can provide valuable information to mitigate personal disease risk, but the
use of genetic results in life insurance underwriting is known to deter many consumers from …

Genetic testing and actuarial science

AS Macdonald - Annals of Actuarial Science, 2024 - cambridge.org
In 1995, Robert Pokorski, MD, wrote a far-seeing article in Nature (Pokorski, 1995) on how
the new world of clinical genetics might affect life insurance. Writing before any actuarial …

Lapse-supported life insurance and adverse selection

O Haçarız, T Kleinow, AS Macdonald - arXiv preprint arXiv:2409.01843, 2024 - arxiv.org
If individuals at the highest mortality risk are also least likely to lapse a life insurance policy,
then lapse-supported premiums magnify adverse selection costs. As an example, we …

Optimal self‐insurance with genetic testing and state‐dependent utility

D Crainich - … Journal of Economics/Revue canadienne d' …, 2024 - Wiley Online Library
I analyze how genetic testing modifies prevention actions that reduce the health and
financial consequences of disease. Specifically, I determine whether individuals adjust their …

Does Ukraine need a specific regulation related to the applying of genetic information for risk assessment in insurance?

M Arych, K Shchubelka, W Wolfsberger… - Finance of …, 2024 - finukr.com.ua
Introduction. The article examines the specifics and role of genetic information for insurance
risk assessment in the life insurance market in Ukraine. Problem Statement. The insurance …

Переваги та недоліки використання генетичних досліджень у страхуванні

МІ Арич, ЯО Каленюк, ММ Левон - 2021 - dspace.nuft.edu.ua
Анотація У статті проведено теоретико-методичне дослідження негативних ризиків і
позитивних можливостей від використання технологій генетичних досліджень у …